Keyphrases
Cytomegalovirus
74%
COVID-19
73%
Cytomegalovirus Infection
47%
Cytomegalovirus Disease
45%
Solid Organ Transplant Recipients
44%
Adenovirus
41%
Antiretroviral Therapy
41%
AIDS/HIV
35%
Virus
35%
Liver Transplantation
32%
Cardiac Implantable Electronic Device Infection
31%
Transplantation
30%
Transplant Recipients
30%
Human Immunodeficiency Virus Type 1 (HIV-1)
29%
Solid Organ Transplantation
28%
Apoptosis
26%
United States
25%
Clinical Outcomes
24%
Confidence Interval
23%
Liver Transplant Recipients
23%
HIV Infection
22%
Opportunistic Infections
21%
Antiviral Drugs
21%
Cardiovascular Implantable Electronic Devices
21%
Tuberculosis
19%
Vaccination
18%
Mayo Clinic
18%
CD4 T Cells
17%
HIV Patients
17%
Risk Factors
17%
High Risk
16%
Human Herpesvirus 6 (HHV-6)
16%
Hospitalization
16%
Periprosthetic Joint Infection
16%
Minnesota
15%
Community-based Participatory Research
15%
Lung Transplantation
14%
Immune Response
14%
Infective Endocarditis
14%
Protease Inhibitors
14%
Hepatitis C Virus
14%
Ganciclovir
14%
T Cells
14%
Epidemiology
13%
Adenovirus Type 5
12%
Adenoviral Vector
12%
Clinical Presentation
12%
Toll-like
12%
Odds Ratio
11%
Clinical High Risk
11%
Cell Death
11%
COVID-19 Pandemic
11%
Monoclonal Antibody
11%
Human Immunodeficiency Virus Infection
11%
Immunocompromised Patients
11%
Fever
10%
Clinical Features
10%
Antiviral Prophylaxis
10%
Chronic Hepatitis C Virus Infection
10%
Retroviral Infection
10%
Kidney Transplant Recipients
10%
Casp8p41
10%
Liver
10%
Moderate to Severe
9%
Bacteremia
9%
Treatment of HIV Infection
9%
Viral Load
9%
Gene Therapy
9%
HIV Protease Inhibitors
9%
Bloodstream Infection
9%
Preemptive Therapy
9%
Clinical Management
9%
Transplant Patients
9%
Haematopoietic Stem Cell Transplant Recipients
9%
Clinical Trials
9%
Infectious Diseases
9%
Rochester
9%
Immunocompromised Host
9%
Device Infection
9%
Viral
8%
Immunosuppression
8%
Kidney
8%
Solid Organ Transplant
8%
Clinical Manifestations
8%
Meta-analysis
8%
Infected Cells
8%
Polyethylene Glycol
8%
Fungal Infection
8%
Endocarditis
8%
Highly Active Antiretroviral Therapy (HAART)
8%
Propionic Acidemia
8%
T Cell Response
8%
Physical Activity
8%
Research Partnerships
8%
Influenza
8%
Mycobacterium Tuberculosis (M. tb)
8%
Antiretroviral
8%
HIV-1 Infection
8%
Solid Organ
8%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
8%
Medicine and Dentistry
Infection
100%
COVID-19
67%
Cytomegalovirus
57%
Cytomegalovirus Infection
56%
Human Immunodeficiency Virus
43%
Diseases
41%
Device Infection
32%
Cardiovascular System
32%
Liver Transplantation
26%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Solid Organ Transplantation
21%
Virus
18%
Liver Graft
17%
Bloodstream Infection
16%
Pathogen
16%
Cohort Effect
15%
Hematopoietic Stem Cell Transplantation
14%
Infective Endocarditis
13%
Monoclonal Antibody
12%
Opportunistic Infection
12%
Antivirus Agent
12%
Prosthetics
12%
Lung Transplantation
11%
Immunocompromised Patient
11%
Kidney Graft
10%
Immigrant
10%
Antiviral Therapy
10%
Clinical Feature
10%
Infectious Arthritis
10%
Allograft
10%
Human Herpesvirus 6
10%
Endocarditis
10%
Virus Infection
10%
Human Immunodeficiency Virus Infection
9%
Antiretroviral Therapy
9%
Infectious Disease
9%
Immunosuppressive Treatment
9%
Adenoviridae
9%
Antiinfective Agent
9%
Systematic Review
9%
Clinical Trial
8%
Viremia
8%
Gene Therapy
8%
Serotype
8%
Odds Ratio
7%
Polymerase Chain Reaction
7%
Ganciclovir
7%
Antiviral Drug
7%
T Cell
7%
Propionic Acidemia
7%
Kidney Transplantation
7%
Programmed Cell Death
7%
Mycosis
7%
Meta-Analysis
6%
Implantable Automatic Defibrillator
6%
Antimicrobial Therapy
6%
Clinician
6%
T-Helper Cell
6%
Left Ventricular Assist Device
6%
Messenger RNA
6%
Adverse Event
6%
Valganciclovir
6%
Hepatitis C Virus
5%
Outpatient
5%
Cohort Analysis
5%
Mycobacteria
5%
Hepatitis C
5%
Intensive Care Unit
5%
Letermovir
5%
Antibiotics
5%
Antibiotic Therapy
5%
Health Care Cost
5%
Mortality Rate
5%
Combination Therapy
5%
Cryptococcosis
5%
Permanent Pacemaker
5%
Public Health
5%
Malignant Neoplasm
5%
Infectious Complication
5%
Comorbidity
5%